AAPL   374.06 (+2.73%)
MSFT   210.91 (+2.25%)
GOOGL   1,500.80 (+2.10%)
AMZN   3,018.76 (+4.44%)
CGC   16.99 (+3.28%)
BABA   238.95 (+6.86%)
TSLA   1,329.48 (+10.00%)
AMD   53.42 (+2.06%)
T   30.45 (+1.23%)
ACB   12.43 (+1.30%)
DIS   113.49 (+1.17%)
NFLX   492.01 (+3.17%)
BA   185.20 (+2.43%)
AAPL   374.06 (+2.73%)
MSFT   210.91 (+2.25%)
GOOGL   1,500.80 (+2.10%)
AMZN   3,018.76 (+4.44%)
CGC   16.99 (+3.28%)
BABA   238.95 (+6.86%)
TSLA   1,329.48 (+10.00%)
AMD   53.42 (+2.06%)
T   30.45 (+1.23%)
ACB   12.43 (+1.30%)
DIS   113.49 (+1.17%)
NFLX   492.01 (+3.17%)
BA   185.20 (+2.43%)
AAPL   374.06 (+2.73%)
MSFT   210.91 (+2.25%)
GOOGL   1,500.80 (+2.10%)
AMZN   3,018.76 (+4.44%)
CGC   16.99 (+3.28%)
BABA   238.95 (+6.86%)
TSLA   1,329.48 (+10.00%)
AMD   53.42 (+2.06%)
T   30.45 (+1.23%)
ACB   12.43 (+1.30%)
DIS   113.49 (+1.17%)
NFLX   492.01 (+3.17%)
BA   185.20 (+2.43%)
AAPL   374.06 (+2.73%)
MSFT   210.91 (+2.25%)
GOOGL   1,500.80 (+2.10%)
AMZN   3,018.76 (+4.44%)
CGC   16.99 (+3.28%)
BABA   238.95 (+6.86%)
TSLA   1,329.48 (+10.00%)
AMD   53.42 (+2.06%)
T   30.45 (+1.23%)
ACB   12.43 (+1.30%)
DIS   113.49 (+1.17%)
NFLX   492.01 (+3.17%)
BA   185.20 (+2.43%)
Log in

NASDAQ:CRVSCorvus Pharmaceuticals SEC Filings & 10K Form

$2.76
+0.16 (+6.15 %)
(As of 07/6/2020 01:51 PM ET)
Add
Compare
Today's Range
$2.66
Now: $2.76
$2.77
50-Day Range
$2.65
MA: $3.29
$4.05
52-Week Range
$1.01
Now: $2.76
$8.10
Volume715 shs
Average Volume104,224 shs
Market Capitalization$77.14 million
P/E RatioN/A
Dividend YieldN/A
Beta2.06

SEC Filings

Corvus Pharmaceuticals (NASDAQ:CRVS) SEC Filings

DateFilerForm TypeView
06/15/2020
4:28 PM
ADAMS STREET PARTNERS LLC (Reporting)
Corvus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2020
4:15 PM
Corvus Pharmaceuticals (Issuer)
Thompson Peter A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2020
4:14 PM
Corvus Pharmaceuticals (Issuer)
Morrison Scott W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2020
4:13 PM
Corvus Pharmaceuticals (Issuer)
Krognes Steve E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2020
4:11 PM
Corvus Pharmaceuticals (Issuer)
Gould Terry P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2020
4:10 PM
Corvus Pharmaceuticals (Issuer)
Grais Linda S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2020
4:07 PM
CLARK IAN T (Reporting)
Corvus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2020
7:15 AM
Corvus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2020
3:38 PM
Corvus Pharmaceuticals (Issuer)
Novo Holdings A/S (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/30/2020
3:35 PM
Corvus Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
04/17/2020
3:13 PM
Corvus Pharmaceuticals (Subject)
ORBIMED ADVISORS LLC (Filed by)
Form SC 13D/A
03/23/2020
4:31 PM
Corvus Pharmaceuticals (Issuer)
Grais Linda S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/23/2020
4:30 PM
CLARK IAN T (Reporting)
Corvus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/23/2020
4:29 PM
Corvus Pharmaceuticals (Issuer)
Krognes Steve E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/23/2020
4:29 PM
Corvus Pharmaceuticals (Issuer)
Morrison Scott W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/23/2020
4:28 PM
Corvus Pharmaceuticals (Issuer)
Thompson Peter A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/23/2020
4:27 PM
Corvus Pharmaceuticals (Issuer)
Gould Terry P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2020
4:25 PM
Corvus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/20/2020
4:17 PM
Corvus Pharmaceuticals (Filer)
Form 424B5
03/19/2020
11:15 PM
Corvus Pharmaceuticals (Filer)
Form EFFECT
03/09/2020
4:12 PM
Corvus Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/05/2020
3:07 PM
Corvus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/18/2020
3:35 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Corvus Pharmaceuticals (Subject)
Form SC 13G/A
02/14/2020
1:52 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Corvus Pharmaceuticals (Subject)
Form SC 13G/A
02/13/2020
7:00 AM
Corvus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/03/2020
7:00 AM
Corvus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/16/2019
3:16 PM
Corvus Pharmaceuticals (Issuer)
Verner Erik J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2019
3:15 PM
Corvus Pharmaceuticals (Issuer)
Mobasher Mehrdad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2019
3:14 PM
Corvus Pharmaceuticals (Issuer)
MILLER RICHARD A MD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2019
3:13 PM
Corvus Pharmaceuticals (Issuer)
LEA LEIV (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2019
3:12 PM
Corvus Pharmaceuticals (Issuer)
Jones William Benton (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2019
5:30 AM
Corvus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2019
8:00 AM
Corvus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2019
3:02 PM
Corvus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/29/2019
3:51 PM
Corvus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2019
4:00 PM
Corvus Pharmaceuticals (Issuer)
Thompson Peter A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2019
3:59 PM
Corvus Pharmaceuticals (Issuer)
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP V LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2019
3:07 PM
Corvus Pharmaceuticals (Issuer)
MILLER RICHARD A MD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2019
3:56 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Corvus Pharmaceuticals (Subject)
Form SC 13G/A
08/01/2019
3:23 PM
Corvus Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/01/2019
3:10 PM
Corvus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/29/2019
3:38 PM
Corvus Pharmaceuticals (Subject)
Novo Holdings A/S (Filed by)
Form SC 13D/A
07/25/2019
6:21 PM
Corvus Pharmaceuticals (Issuer)
Novo Holdings A/S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2019
3:22 PM
Corvus Pharmaceuticals (Subject)
ORBIMED ADVISORS LLC (Filed by)
Form SC 13D/A
07/01/2019
5:16 PM
Corvus Pharmaceuticals (Issuer)
Thompson Peter A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2019
5:15 PM
Corvus Pharmaceuticals (Issuer)
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP V LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2019
3:09 PM
ADAMS STREET PARTNERS LLC (Reporting)
Corvus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2019
3:07 PM
Corvus Pharmaceuticals (Issuer)
Krognes Steve E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2019
3:06 PM
Corvus Pharmaceuticals (Issuer)
Morrison Scott W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2019
3:05 PM
Corvus Pharmaceuticals (Issuer)
Gould Terry P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2019
3:05 PM
Corvus Pharmaceuticals (Issuer)
Grais Linda S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2019
3:05 PM
Corvus Pharmaceuticals (Issuer)
Thompson Peter A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2019
3:05 PM
CLARK IAN T (Reporting)
Corvus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2019
7:00 PM
Corvus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/17/2019
3:08 PM
Corvus Pharmaceuticals (Issuer)
MILLER RICHARD A MD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2019
3:55 PM
Corvus Pharmaceuticals (Issuer)
MILLER RICHARD A MD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2019
3:12 PM
Corvus Pharmaceuticals (Issuer)
LEA LEIV (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2019
7:30 AM
Corvus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2019
3:40 PM
Corvus Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/09/2019
3:29 PM
Corvus Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/09/2019
3:04 PM
Corvus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/24/2019
3:14 PM
Corvus Pharmaceuticals (Filer)
Form DEFA14A
04/24/2019
3:10 PM
Corvus Pharmaceuticals (Filer)
Form DEF 14A
03/07/2019
3:15 PM
Corvus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2019
3:30 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Corvus Pharmaceuticals (Subject)
Form SC 13G/A
02/13/2019
10:50 AM
Corvus Pharmaceuticals (Subject)
FMR LLC (Filed by)
Form SC 13G/A
02/06/2019
7:35 AM
Corvus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/31/2019
1:25 PM
Corvus Pharmaceuticals (Subject)
Novo Holdings A/S (Filed by)
Form SC 13D/A
01/30/2019
3:08 PM
Corvus Pharmaceuticals (Issuer)
Grais Linda S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2019
3:07 PM
Corvus Pharmaceuticals (Issuer)
Mobasher Mehrdad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2019
3:05 PM
Corvus Pharmaceuticals (Issuer)
Mobasher Mehrdad (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/30/2019
3:05 PM
Corvus Pharmaceuticals (Issuer)
Grais Linda S (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/28/2019
3:10 PM
Corvus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2019
7:35 AM
Corvus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2019
7:30 AM
Corvus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/31/2018
3:16 PM
Corvus Pharmaceuticals (Issuer)
MILLER RICHARD A MD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2018
3:08 PM
Corvus Pharmaceuticals (Issuer)
LEA LEIV (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2018
3:05 PM
Corvus Pharmaceuticals (Issuer)
MILLER RICHARD A MD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/14/2018
3:15 PM
Corvus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/14/2018
3:09 PM
Corvus Pharmaceuticals (Issuer)
Jones William Benton (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/14/2018
3:07 PM
Corvus Pharmaceuticals (Issuer)
MILLER RICHARD A MD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/14/2018
3:06 PM
Buggy Joseph J (Reporting)
Corvus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/14/2018
3:06 PM
Corvus Pharmaceuticals (Issuer)
LEA LEIV (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/14/2018
3:05 PM
Corvus Pharmaceuticals (Issuer)
Hunt Daniel W. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/14/2018
3:05 PM
Corvus Pharmaceuticals (Issuer)
Verner Erik J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2018
3:05 PM
Corvus Pharmaceuticals (Issuer)
MILLER RICHARD A MD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2018
3:06 PM
Corvus Pharmaceuticals (Issuer)
MILLER RICHARD A MD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2018
7:30 AM
Corvus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/01/2018
3:41 PM
Corvus Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/01/2018
3:15 PM
Corvus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/22/2018
7:35 AM
Corvus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/03/2018
3:15 PM
Corvus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/17/2018
4:06 PM
Corvus Pharmaceuticals (Filer)
Form 10-K/A
08/02/2018
3:23 PM
Corvus Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/02/2018
3:20 PM
Corvus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/28/2018
7:35 AM
Corvus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/25/2018
3:15 PM
ADAMS STREET PARTNERS LLC (Reporting)
Corvus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2018
3:06 PM
Corvus Pharmaceuticals (Issuer)
Thompson Peter A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2018
3:05 PM
Corvus Pharmaceuticals (Issuer)
Morrison Scott W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2018
3:05 PM
Corvus Pharmaceuticals (Issuer)
Gould Terry P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 7/6/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.